Pacira BioSciences (NASDAQ:PCRX) Friday announced the pricing of $250.0 million aggregate principal amount of convertible senior notes due 2029 in a private placement to qualified institutional buyers...
Source LinkPacira BioSciences (NASDAQ:PCRX) Friday announced the pricing of $250.0 million aggregate principal amount of convertible senior notes due 2029 in a private placement to qualified institutional buyers...
Source Link
Comments